Black Diamond Therapeutics, Inc. (BDTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -10.23M | -6.79M | -7.85M | -9.16M | 53.41M | -15.05M | -11.32M | -14.73M | -21.2M | -13.96M | -18.36M | -14.37M |
| Operating CF Margin % | - | - | - | - | 76.3% | - | - | - | - | - | - | - |
| Operating CF Growth % | -119.16% | 54.92% | 30.67% | 37.8% | 351.95% | -7.87% | 38.33% | -2.49% | -5.83% | 36.39% | -11.45% | 20.47% |
| Net Income | -9.04M | -15.12M | -8.5M | -10.56M | 56.54M | -15.98M | -15.56M | -19.91M | -18.23M | -19.41M | -23.01M | -19.15M |
| Depreciation & Amortization | 27K | 66K | 86K | 86K | 87K | 85K | 86K | 86K | 86K | 86K | 115K | 114K |
| Stock-Based Compensation | 0 | 1.41M | 0 | 1.78M | 1.7M | 1.64M | 1.99M | 5.29M | 1.71M | 1.54M | 2.75M | 2.65M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -170K | 0 |
| Other Non-Cash Items | 1.83M | 7.84M | 2.24M | 344K | 341K | 25K | -320K | -406K | -204K | -95K | 708K | 719K |
| Working Capital Changes | -3.05M | -988K | -1.68M | -805K | -5.26M | -816K | 2.48M | 217K | -4.57M | 3.92M | 1.24M | 1.3M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.39M | -396K | 204K | -1.86M | -1.38M | 2.04M | 1.21M | -433K | -1.13M | 1.63M | -1.86M | -343K |
| Cash from Investing | 19.5M | -2.89M | 8.59M | -59.15M | 8.55M | 27.77M | 2.19M | 740K | -13.73M | 12.25M | -37.88M | 17.18M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -33K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 3K | 1K | 10K | 0 | 0 | 0 | 38K | 0 | 0 | 37.85K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 71K | 0 | 3K | 13K | 8K | 48K | 0 | 0 | 0 | -37.85K | 95K |
| Cash from Financing | -185K | -196K | 134K | -116K | 32K | 291K | -252K | 21.38M | 4.13M | -46K | 71.93M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | -196K | 134K | -116K | 32K | 0 | -500K | 21.01M | 3.98M | 0 | 71.85M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -185K | 0 | 0 | 0 | 0 | 291K | 248K | 364K | 150K | -46K | 77K | 0 |
| Net Change in Cash | 9.08M | -9.87M | 874K | -68.43M | 61.99M | 13.01M | -9.38M | 7.39M | -30.8M | -1.75M | 15.68M | 2.81M |
| Free Cash Flow | -10.23M | -6.79M | -7.85M | -9.16M | 53.41M | -15.05M | -11.32M | 0 | -21.2M | -13.96M | -18.39M | -14.37M |
| FCF Margin % | - | - | - | - | 76.3% | - | - | - | - | - | - | - |
| FCF Growth % | -119.16% | 54.92% | 30.67% | - | 351.95% | -7.87% | 38.45% | 100% | -5.83% | 36.39% | -11.7% | 21.31% |
| FCF per Share | -0.18 | -0.12 | -0.14 | -0.16 | 0.93 | -0.27 | -0.20 | - | -0.41 | -0.29 | -0.36 | -0.39 |
| FCF Conversion (FCF/Net Income) | 1.13x | 0.45x | 0.92x | 0.87x | 0.94x | 0.94x | 0.73x | 0.74x | 1.16x | 0.72x | 0.80x | 0.75x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |